Expected news7 Sep 2018 09:51
Factom-Series B, Updated valuation and close of funding. (FFWD has option to increase)
Intensity- Clinical Trial results, close of series B, (FFWD has warrants to increase stake)
Juvenescence- Series B. Must be 50% higher in valuation or anti dilution shares issued.
£4m in cash, the board have recent said that cannabis, blockchain, AI is the sectors are of interest.